A carregar...

Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

The cannabinoid 1 (CB(1)) receptor antagonist rimonabant (SR141716) alters rewarding properties and intake of food and drugs. Additionally, striatal dopamine D2 receptor (DRD2) availability has been implicated in reward function. This study shows that chronic treatment of rats with rimonabant (1.0 a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crunelle, Cleo L., van de Giessen, Elsmarieke, Schulz, Sybille, Vanderschuren, Louk J.M.J., de Bruin, Kora, van den Brink, Wim, Booij, Jan
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3252421/
https://ncbi.nlm.nih.gov/pubmed/21955259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1369-1600.2011.00369.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!